Mapp Biopharmaceutical
Larry Zeitlin is the current president at Mapp Biopharmaceutical. Larry has previously worked as a senior scientist at Epicyte, research scientist at ReProtect, and president at Mapp Biopharmaceutical. Zeitlin has over 20 years of experience in the biotechnology industry.
Larry Zeitlin received a Bachelor's degree in Biophysics from Johns Hopkins University and then went on to receive a Doctor of Philosophy (Ph.D.) in Reproductive Biology from The Johns Hopkins University.
Larry Zeitlin reports to Kevin Whaley, CEO.
This person is not in the org chart
This person is not in any offices
Mapp Biopharmaceutical
Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.